NEO

NEO EBITDA Growth

145.26%TTM

Period ending:

NEO TTM EBITDA YoY %%
NEO TTM EBITDA YoY %6679.30%-51027.88%
2001-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

NEO ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 98 observations from Sep 30, 2001 to Jun 30, 2026.

Neogenomics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
145.2649%
-35,975.2688%
-2,500.5295%
-9,056.7198%
-639.4286%
99.1699%
91.4182%
98.5691%
92.4649%
82.7586%
78.0171%
68.5036%
36.5977%
-342.2389%
-277.019%
-207.9095%
-173.826%
88.5437%
57.8%
358.531%
544.228%
-60.5238%
-23.8008%
-45.3837%
-50.9268%
22.8593%
18.5501%
9.9198%
28.3139%
4.8726%
24.5575%
73.6917%
18.053%
19.6706%
-1.1674%
-20.9115%
24.103%
85.3982%
316.341%
211.8077%
152.2593%
70.9559%
-21.1886%
3.8947%
-10.0556%
-5.8711%
3.5992%
11.787%
74.9136%
64.7046%
50.7952%
41.2471%
-5.8201%
34.9886%
199.9404%
650.3215%
1,094.7368%
386.7372%
241.8782%
129.3396%
73.7513%
-11.3684%
-117.8834%
-5,009.4187%
-581.5344%
-473.822%
-277.5223%
96.0548%
122.7888%
94.7421%
34.5552%
-99.5304%
-45,443.3134%
-841.241%
-509.212%
-954.9135%
159.5593%
166.2172%
116.0771%
65.2058%
1.1091%
-19.8095%
-29.0428%
-35.6339%
-40.3222%
-143.5784%
-147.3026%
-133.6633%
-130.8715%
115.6697%
114.5854%
119.0006%
118.5547%
-621.8637%
-512.3908%
-562.0022%
-724.7386%
-67.8216%

Compare ebitda growth

All NEO financial metrics · NEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.